NCT00245297View on ClinicalTrials.gov

Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes.

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

April 30, 2006

Conditions
Haemophilia A
Interventions
DRUG

Kogenate FS, reconstituted in a suspension of liposomes

Trial Locations (3)

125167

Center for Hematological Research, Department of Reconstructive Orthopedic Surgery, Moscow

The Russian Academy of Medical Sciences, Haemophilia Center, Moscow

191186

Republic Haemophilia Center., Saint Petersburg

All Listed Sponsors
lead

Recoly N.V.

INDUSTRY